Opus Point Partners Management, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 191 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$240,000
-25.9%
4,8060.0%0.36%
-19.1%
Q1 2019$324,000
+37.3%
4,806
-6.0%
0.44%
-15.4%
Q4 2018$236,000
-79.7%
5,115
-66.1%
0.52%
-81.3%
Q3 2018$1,165,000
-12.7%
15,102
-4.6%
2.78%
-3.9%
Q2 2018$1,334,000
+1.9%
15,833
-1.1%
2.89%
+12.7%
Q1 2018$1,309,000
-20.2%
16,002
-44.3%
2.57%
+80.9%
Q4 2017$1,641,000
-26.3%
28,704
-13.9%
1.42%
-28.9%
Q3 2017$2,226,000
+46.7%
33,347
+13.1%
2.00%
+43.7%
Q2 2017$1,517,000
-54.8%
29,482
-48.6%
1.39%
-44.2%
Q1 2017$3,353,000
+44.7%
57,410
+3.4%
2.49%
+34.8%
Q4 2016$2,317,000
-19.8%
55,524
+1.5%
1.85%
+14.0%
Q3 2016$2,889,000
+59.3%
54,692
+26.3%
1.62%
-7.5%
Q2 2016$1,814,000
-12.4%
43,295
-15.1%
1.75%
+9.4%
Q1 2016$2,071,000
-6.2%
51,000
+50.0%
1.60%
+9.8%
Q4 2015$2,207,000
-32.0%
34,000
-26.1%
1.46%
-18.7%
Q3 2015$3,247,000
+587.9%
46,000
+820.0%
1.79%
+352.8%
Q1 2015$472,000
-4.6%
5,000
+13.2%
0.40%
-19.2%
Q4 2014$495,0004,4160.49%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders